Systemic Metabolic Alteration Dependent on the Thyroid‐Liver Axis in Early PD
Authors:
Open Access
- 4 October 2022
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 93 (2) , 303-316
Abstract
Objective: Parkinson's disease (PD) is a common neurodegenerative disease characterized by initial involvement of the olfactory bulb/amygdala or autonomic nerves followed by nigral degeneration. Although autonomic innervation strictly regulates multiorgan systems, including endocrine functions, circulation, and digestion, how dysautonomia in PD affects systemic metabolism has not been identified. In this study, we tried to estimate the pathogenic linkage of PD by nuclear medicine techniques, trans‐omic analysis of blood samples, and cultured cell experiments.Methods: Thyroid mediastinum ratio of 123I‐metaiodobenzylguanidine (MIBG) scintigraphy was measured in 1,158 patients with PD. Furthermore, serum exosome miRNA transcriptome analysis and plasma metabolome analysis followed by trans‐omic analysis were performed in patients with de novo PD and age‐matched healthy control persons. Additionally, thyroid hormone was administered to skeletal muscle and liver derived cells to evaluate the effect of hypothyroidism for these organs.Results: Sympathetic denervation of thyroid correlating with its cardiac denervation was confirmed in 1,158 patients with PD by MIBG scintigraphy. Among patients with drug‐naïve PD, comprehensive metabolome analysis revealed decreased levels of thyroxine and insufficient fatty acid β‐oxidation, which positively correlate with one another. Likewise, both plasma metabolome data and transcriptome data of circulating exosomal miRNAs, revealed specific enrichment of the peroxisome proliferator‐activated receptor (PPARα) axis. Finally, association of thyroid hormone with PPARα‐dependent β‐oxidation regulation was confirmed by in vitro experiments.Interpretation: Our findings suggest that interorgan communications between the thyroid and liver are disorganized in the early stage of PD, which would be a sensitive diagnostic biomarker for PD. ANN NEUROL 2023;93:303–316Keywords
Funding Information
- Japan Agency for Medical Research and Development (19ak0101112h0001, JPMJMS2024)
- Japan Society for the Promotion of Science (15H04843, 18H02744, 18KK0242, 18KT0027, 22H02986, 22K19512)
- Japan Science and Technology Agency
This publication has 55 references indexed in Scilit:
- Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with (123I) ioflupane in diagnosis of parkinsonian syndromesJournal of Neurology, Neurosurgery & Psychiatry, 2013
- Integrated pathway-level analysis of transcriptomics and metabolomics data with IMPaLABioinformatics, 2011
- T3-mediated expression of PGC-1α via a far upstream located thyroid hormone response elementMolecular and Cellular Endocrinology, 2008
- Axonal -synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's diseaseBrain, 2007
- Degeneration of Cardiac Sympathetic Nerve Begins in the Early Disease Process of Parkinson’s DiseaseBrain Pathology, 2007
- Functional Bowel DisordersGastroenterology, 2006
- Sympathetic nervous system activity in rat thyroid: potential role in goitrogenesisAmerican Journal of Physiology-Endocrinology and Metabolism, 2005
- Orthostatic hypotension from sympathetic denervation in Parkinson’s diseaseNeurology, 2002
- Neuronal pathways to the rat thyroid revealed by retrograde tracing and immunocytochemistryNeuroscience, 1988
- DOPAMINE IS A PHYSIOLOGICAL REGULATOR OF THYROTROPHIN (TSH) SECRETION IN NORMAL MANClinical Endocrinology, 1979